Skip to main content
CDC Website

World Health Organization

A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities

This book was developed to assist in the management of TB and HIV/AIDS programs that are implementing or planning to implement collaborative TB/HIV activities. It is intended to facilitate the collection of standardized data and help in the interpretation and dissemination of these data for program improvement. It aims to ensure consistency across all agencies and stakeholders involved in HIV/AIDS, TB, and collaborative TB/HIV activities.

Adherence to Long-Term Therapies: Evidence for Action

This report provides a critical review of what is known about adherence to long-term therapies.This is achieved by looking beyond individual diseases. A broad range of policy options emerges by including communicable diseases such as tuberculosis and human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), mental and neurological conditions such as depression and epilepsy, substance dependence (exemplified by smoking cessation), hypertension, asthma and palliative care for cancer.

How Human Immunodeficiency Virus Voluntary Testing Can Contribute to Tuberculosis Control

This report sets out the rationale for the ProTest Initiative (Promotion of Voluntary Testing), based on an analysis of the impact of HIV on TB control. It describes the elements of the ProTest approach, reviews progress so far, and sets out the future direction. The purpose of the report is to generate discussion and ideas that will help the Initiative establish a comprehensive range of interventions needed to control TB in settings with high prevalence of HIV infection.

Global Tuberculosis Report 2017

WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.